APPLICATIONS PUBLISHED 14 AUGUST 2002
Published: 1-Feb-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
A method for chemoprevention of prostate cancer
The University of Tennessee Research Corporation 1229903*
A method for producing a moulded body containing starch
Greither, Peter 1229904*
Transdermal drug delivery devices comprising (R)-(Z)-1-azabicyclo[2.2.1]heptan-3-one,)-[3(3-methoxyphenyl)-2-propynyl]oxime
3M Innovative Properties Company 1229905*
Mesoprogestins for the treatment and prevention of benign hormone dependent gynaecological disorders
Jenapharm 1229906*
Prevention of plaque rupture by ACAT inhibitors
Warner-Lambert 1229907*
Use of NSAIDS for the treatment of pancreatic cancer
Advanced Research and Technology Institute; Marshall, Mark; Sweeney, Christopher; Yip-Schneider, Michelle; Crowell, Pamela 1229908*
Transdermal delivery of lasofoxifene
Watson Pharmaceuticals 1229909*
Integrin receptor antagonists
Merck & Co 1229910*
Protease inhibitors
SmithKline Beecham 1229911*
Protease inhibitors
SmithKline Beecham 1229912*
Substituted 1-benzazepines and derivatives thereof
Antexpharma 1229913*
Protease inhibitors
SmithKline Beecham 1229914*
Combination chemotherapy
Warner-Lambert 1229916*
Pharmaceutical compsns and preparations for the treatment of metabolic bone disease
Yoyu Industrial Company 1229917*
Pharmaceutical compsn comprising a combination of metformin and glibenclamide
Bristol-Myers Squibb 1229918*
A method if effecting phosphorylation in eucaryotic cells using thiamine triphosphate
Institut Pasteur 1229919*
Therapy with 2-5A and interferon
The Cleveland Clinic Foundation 1229920*
Heparanase inhibitors for the treatment of heart failure
Abbott 1229921*
Aplidine treatment of cancers
Pharma Mar 1229922*
Inhibition of pathogens by Bacillus coagulans strains
Ganeden Biotech 1229923*
Targeted bifunctional molecules and therapies based thereon
The Board of Trustees of the Leland Stanford University 1229924*
Inhibitors of Helicobacter pylori induced gastrointestinal diseases
Axxima Pharmaceuticals 1229925*
Pharmaceutical compsn for the treatment of diarrhoea
Karolinska Innovations 1229926*
Use of a growth hormone or a growth hormone secretagogue for appetite suppression or induction of satiety
Novo Nordisk 1229927*
Use of salmonella vectors for vaccination against Helicobacter infection
Oravax 1229928*
Vaccines for Mycoplasma bovis and methods of use
Biomune 1229929*
Compsns and methods for treatment of allergic disorders
Probiall 1229930*
Fusion proteins of Mycobacterium tuberculosis
Corixa Corp 1229931*
Induction of mucosal immunity by vaccination via the skin route
Powderject Vaccines 1229932*
Immunomodulatory compsns containing an immunostimulatory sequence linked to antigen and methods of use thereof
Dynavax Technologies Corp 1229933*
Compsns and methods for treating cancer using immunoconjugates and chemotherapeutic agents
Immunogen 1229934*
Treatment of cell malignancies using anti-CD40L antibodies in combination with anti-CD20 antibodies and/or chemotherapeutics and radiotherapy
Idec Pharmaceuticals 1229935*
Use of anti-idiotypical antibodies as vaccines against cancer
Igeneon Krabs-Immuntherapie Forschungs und Entwicklungs 1229936*
Potentiation of prodrug efficacy
Hybridon 1229938*
Use of histamine as a drug delivery enhancing compound for use in transmucosal delivery
Maxim Pharmaceuticals 1229939*
